In a few decades, gene-editing technologies could reduce the likelihood of common human diseases. Societies must use this ...

A new technology, mvGPT, is capable of precisely editing genes, activating gene expression, and repressing genes all at the ...

(Nasdaq: MGX), a precision genetic medicines company committed to developing curative therapeutics for patients using its proprietary gene editing toolbox, today provided updates on the successful ...

A team of scientists claims that the risk of common conditions like heart disease could be slashed by editing people's ...

Genetic changes are a significant cause of infertility, impacting over 15% of the global population. TLE6, a major protein ...

We are excited to welcome Eric to our Board of Directors,” said Brian C. Thomas, PhD, CEO and founder of Metagenomi. “His tremendous track record in the pharmaceutical industry as well as his ...

The de-extinction company led by CEO Ben Lamm has raked in $435 million in funding since its launch. He believes it has ...

Bank of America Securities analyst Alec Stranahan maintained a Sell rating on Editas Medicine (EDIT – Research Report) yesterday and set a ...

Picture of a tomato plant with an unfavorable natural mutation (on the left) and a tomato plant in with the mutation was repaired by genome editing (on the right). The repair of the mutation leads ...

Researchers have opened a transformative chapter in agricultural biotechnology by unveiling virus-induced genome editing ...

The adenine base editor corrected the most common mutation associated with Stargardt disease in the ABCA4 gene with no off-target effects.